Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

150.40
Delayed Data
As of 3:59pm ET
 -0.34 / -0.23%
Today’s Change
89.76
Today|||52-Week Range
314.88
+0.70%
Year-to-Date
No recent news for Intercept Pharmaceuticals Inc.

Today’s Trading

Previous close150.74
Today’s open150.63
Day’s range146.09 - 151.06
Volume301,120
Average volume (3 months)713,991
Market cap$3.7B
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)+29.86%
Earnings growth (this year)-67.38%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+59.74%
P/E ratioNM
Price/Sales1,272.01
Price/Book6.11

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+0.70+2.17%
NBIXNeurocrine Bioscienc...+1.13+2.48%
GRFSGrifols SA+0.18+1.15%
CBPOChina Biologic Produ...+3.43+2.93%
Data as of 3:59pm ET, 05/02/2016

Financials

Next reporting dateMay 6, 2016
EPS forecast (this quarter)-$3.82
Annual revenue (last year)$2.8M
Annual profit (last year)-$226.4M
Net profit margin-8,139.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs